Statins in the spectrum of neurologic disease

Area of Science:

• Cardiovascular Medicine
• Neurology
• Pharmacology

Background:

• Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are established for cardiovascular disease prevention.
• Atherosclerosis, linked to hypercholesterolemia and inflammation, is a primary cause of heart disease.
• Statins exhibit multifaceted effects on these cardiovascular risk factors.

Purpose of the Study:

• To review the growing evidence for statin efficacy in neurologic diseases.
• To explore the diverse therapeutic applications of statins beyond cardiovascular health.
• To understand the shared pathogenetic mechanisms underlying neurologic conditions and statin's pharmacodynamic effects.

Main Methods:

• Literature review of existing evidence on statin use in cardiovascular and neurologic diseases.
• Analysis of statin's pharmacodynamic effects in relation to disease mechanisms.
• Synthesis of data on statin benefits across various neurologic conditions.

Main Results:

• Statins are safe and effective for primary and secondary prevention of cardiovascular disease.
• Mounting evidence supports statin benefits in diverse neurologic conditions, including stroke, neurodegenerative diseases, and brain injury.
• Statins demonstrate efficacy in treating rare neurometabolic storage diseases and central nervous system inflammation.

Conclusions:

• Statins possess a formidable and expanding range of therapeutic applications in neurology.
• Shared pathogenetic mechanisms in neurologic diseases contribute to the broad efficacy of statins.
• The manifold pharmacodynamic effects of statins underpin their utility in treating a wide spectrum of neurologic disorders.